Interstitial Lung Diseases (ILD) Complete

This test measures several attributes to provide a comprehensive evaluation of ILDs. These include:

• Rheumatoid Arthritis Serum: Measures the presence of antibodies associated with rheumatoid arthritis
• Anti CCP: Detects anti-cyclic citrullinated peptide antibodies that are indicative of rheumatoid arthritis
• ANA Profile Serum (9 Antigen + ANA IF): Evaluates the presence of antinuclear antibodies (ANAs) associated with autoimmune diseases
• CRP: Measures C-reactive protein levels, which indicate inflammation in the body
• ACE: Assesses the levels of angiotensin-converting enzyme, which can be elevated in certain lung diseases
• Aldolase: Determines the levels of aldolase, an enzyme linked to muscle damage
• Myositis Profile-IgG (16 Antigen): Tests for various antibodies associated with myositis, a group of inflammatory muscle diseases
• Hypersensitive pneumonitis panel: Evaluates antibodies related to hypersensitivity pneumonitis, an immune-mediated lung disease

• Aid in the diagnosis and monitoring of ILDs, such as idiopathic pulmonary fibrosis, sarcoidosis, and connective tissue-related lung diseases
• Assess disease activity, severity, and response to treatment
• Identify specific antibodies or markers that help differentiate between different ILDs
• Rule out other conditions that can mimic ILDs, such as rheumatoid arthritis or myositis

This test is recommended for individuals who:

• Present with symptoms of ILDs, including shortness of breath, persistent cough, fatigue, and unexplained weight loss
• Have a family history of ILDs or a known genetic predisposition
• Show signs of autoimmunity or have been diagnosed with rheumatoid arthritis, myositis, or other autoimmune diseases
• Require ongoing monitoring of their ILD condition, especially when starting or adjusting treatment

This test provides valuable information that aids in diagnosis and treatment decisions. Abnormal results may indicate the presence of ILDs or other related conditions. However, abnormal results alone cannot confirm a specific diagnosis. Further evaluation, including imaging tests and additional diagnostic procedures, are often required. It is essential to discuss your test results with your doctor for proper interpretation and guidance.

• A blood sample will be taken from your arm.
• The sample will be analysed using various methods specific to each individual test included in the ILD Complete panel.
• The process usually takes a few minutes for blood collection.
• Discomfort during blood collection is minimal, resembling a brief pinch or prick.

• Fasting is not necessary; you can eat and drink as usual.
• Inform your doctor about any medications you are taking, as certain drugs might interfere with the test results.
• Follow any specific instructions provided by your doctor regarding medication adjustments or discontinuation.

• High-resolution computed tomography (HRCT) scan: Provides detailed images of the lungs, helping to identify lung abnormalities
• Pulmonary function tests: Measure lung capacity and airflow to evaluate lung function
• Bronchoscopy: Involves the insertion of a flexible tube into the airways to collect samples or perform a biopsy.

Interstitial Lung Disease Complete Profile

Interstitial lung disease (ILD) refers to a group of conditions characterised by inflammation and scarring of the lung tissue. These diseases can result from various causes, such as exposure to toxins, autoimmune disorders, infections, and other underlying medical conditions. ILDs often lead to breathing difficulties, reduced lung function, and impaired gas exchange in the lungs. Early detection and proper management are crucial for optimal outcomes.